More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
Hayley Williams releases new solo album “Ego Death at a Bachelorette Party” with “Parachute”Hayley Williams has released her latest solo album, Ego Death at a Bachelorette Party, which comprises 17 previously shared tracks and a ne...
There has to be an edge for wealth creation & protection: 6 midcap stocks with an upside potential of up to 55%A pharma company that has been performing well post-restructuring, an auto ancillary firm whose product has remained the preferred choice f...
Looking at mid-caps? Keep your portfolio healthy: 5 mid-cap pharma stocks with an upside potential of up to 38%Even as the bears are running wild on the street causing across-the-board damage, there are sectors that have kept them at bay. And that’s ...
As smog engulfs the street, essential pills for a healthy of portfolio: 5 pharma stocks with an upside potential of up to 39%Here’s a lesson from history: For a long-term investor, buying in a correcting market is mostly an opportunity. The operative part, of cour...
Pharma sector: Turnaround for good, 6 small and mid cap pharma stocks with upside potential of up to 32%While it might not have been making it headline, the pharmaceutical sector or commonly called as pharma has come through a tough period due...
Comeback and re-rating supported by numbers? 5 pharma stocks with upside potential of up to 21%Both at the real business condition and on the valuation cycle on the street. The Indian pharmaceutical sector has undergone significant ch...
For risk takers; 4 smallcaps with right mix of ROE and ROCE and having an upside scope of up to 26%While small caps have been moving upward for the last many weeks, as the nifty touches a new high every second day, higher participation of...
Stocks in the news: ONGC, IIFL Securities, YES Bank, Aurobindo Pharma and RILSterlite Technologies bagged a Rs 1,800 crore project from Telangana Fiber Grid Corp
Aurobindo Pharma Inc recalls Mirtazapine tablets in USThe product is being recalled due to a label error on declared strength. Bottles labelled as Mirtazapine 7.5 mg may contain 15 mg tablets, ...
Zydus Cadila gets USFDA nod for anti depressantZydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market the Mirtazapine orally disintegrating t...
- Surya Pharma launches neuropsychiatric division
The Rs 1,600-crore Surya Pharmaceutical has launched its Super speciality Neuropsychiatric division called ALVIN .